Abstract
A new class of human GST inhibitors has been identified via rational design approach; we report their discovery, synthesis, inhibitory activity, and synergetic effect in combination with cisplatin against A549 lung cancer cell line. The results of this effort show that the lead 4-O-decyl-gabosine D (24) has optimum synergetic effect in A549 human lung adenocarcinoma epithelial cell and that this activity involves inhibition of glutathione S-transferase M1, apparently consistent with siRNA-mediated knockdown of GSTM1 gene. (Figure presented)
Original language | English |
---|---|
Pages (from-to) | 8574-8581 |
Number of pages | 8 |
Journal | Journal of Medicinal Chemistry |
Volume | 54 |
Issue number | 24 |
DOIs | |
Publication status | Published - 2011 Dec 22 |
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery